Hempfusion Wellness Inc.

Hempfusion Wellness Inc.

CBDHF
Hempfusion Wellness Inc.US flagOther OTC
0.00
USD
- -
- -
1,635.00Market Cap
Hempfusion Wellness Inc.
CBDHF
(Other OTC)

Recent

price

0.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2016
2017
2018
2019
2020
TTM
FRC
- -
0.01
0.01
0.03
0.03
0.04
Revenue per Share
-0.01
-0.01
-0.01
-0.1
-0.33
-0.36
Basic EPS, GAAP
-0.01
-0.01
-0.02
-0.1
-0.13
-0.18
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
-0.01
-0.02
0.25
-0.08
-0.08
Book Value per Share
- -
-0.01
-0.02
0.2
-0.03
0.12
Tangible Book Value per Share
117
117
117
117
117
117
Basic Weighted Avg Shares
- -
1
1
3
4
4
Sales/Revenue/Turnover
-554
-130.35
-117.15
-404.57
-500.61
-543.04
Operating Margin (%)
- -
- -
- -
- -
1
- -
Depreciation Expense
-1
-1
-2
-12
-38
-42
Net Income, GAAP
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
-558
-157.45
-129.94
-402.83
-992.73
-968.16
Profit Margin (%)
- -
-1
3
24
-4
13
Working Capital
- -
- -
- -
- -
- -
- -
LT Debt
- -
-1
3
31
-4
14
Total Equity
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
-1,448.7
Return on Common Equity (%)

Capital Structure

FRC

in mil. unless spec.
Dec'20
Mar'21
Jun'21
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
117
117
117
Market Capitalization
- -
227
45

Working Capital

FRC

in mil. unless spec.
Dec'20
Mar'21
Jun'21
Total Current Assets
14
23
16
Cash, Cash Equivalents & STI
9
17
11
Accounts Receivable, Net
- -
- -
- -
Inventories
3
3
3
Total Current Liabilities
18
3
3
Payables & Accruals
4
3
3
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
-111.45%
Free Cash Flow
- -
- -
28.1%
Net Income, GAAP
- -
- -
212.36%
Sales/Revenue/Turnover
- -
- -
26.75%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2019
1
1
- -
- -
3
2020
1
1
1
1
4
2021
1
1
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2019
-0.04
- -
- -
- -
-0.1
2020
-0.04
-0.03
-0.14
- -
-0.33
2021
-0.05
-0.06
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2019
- -
- -
- -
- -
- -
2020
- -
- -
- -
- -
- -
2021
- -
- -
- -
- -
- -
Business
Hempfusion Wellness Inc. is a health and wellness company specializing in the development, manufacturing, marketing, and distribution of hemp-derived cannabidiol (CBD) products and probiotic supplements. The company offers an extensive portfolio that includes tinctures, capsules, gummies, topicals such as pain relief creams, wound healing ointments, and skin care products under its flagship HempFusion brand, as well as the Sagely Naturals and Apothecanna brands. Its products are manufactured under current Good Manufacturing Practice (cGMP) standards and cover broad-spectrum CBD and whole-food hemp extracts combined with other natural ingredients. Hempfusion Wellness markets over 100 SKUs in approximately 18,000 retail stores across the United States and internationally, with e-commerce platforms serving as additional distribution channels. The company targets health-conscious consumers seeking premium CBD and probiotic wellness products. Founded in 2019 and headquartered in Denver, Colorado, Hempfusion Wellness has recently undertaken significant business changes including expanding its retail distribution network into top U.S. supermarket chains to increase store presence by thousands of locations. The company has achieved self-affirmed Generally Recognized As Safe (GRAS) status for its proprietary hemp-derived CBD extract, facilitating its use in foods, beverages, and dietary supplements, positioning it for expanded retail acceptance amid evolving FDA regulatory landscapes. Hempfusion has also focused on launching new ingestible and topical CBD products, broadening its product innovation pipeline. Despite operational challenges in past years, including financial filings delays, Hempfusion Wellness maintains a strategic emphasis on cost-saving initiatives, ongoing product development, and expanding global footprint with targeted growth in Europe, Asia, and Latin America. These strategic moves support its goal to enhance market share and revenue, with a clean balance sheet and efforts to scale e-commerce and retail distribution channels effectively.

Company News

APIChatGPT
  • Hempfusion Wellness completes sale of assets and operations of probiotic business to Kadenwood

  • HempFusion Wellness reports a rise in Q4 and fiscal 2021 revenue amid declining costs

  • HempFusion Wellness announces brokered private placement to raise up to US$3.0M in aggregate gross proceeds

  • HempFusion Wellness says its hemp-derived CBD extract achieves “major regulatory milestone”

  • HempFusion Wellness unveils $4M annual savings initiative and updates on retail growth

  • Hempfusion Wellness Inc. (CBDHF) CEO Dr. Jason Mitchell on Q3 2021 Results - Earnings Call Transcript

  • HempFusion Wellness reports year-over-year, triple-digit increase in 3Q revenue

  • HempFusion's Q3 Revenue Spikes 155% YoY, Accelerates Sales Activity in Q4

  • HempFusion drives growth with its popular hemp-based CBD and probiotic products

  • HempFusion launches ingestible and topical CBD products into another Top 15 US supermarket chain

  • HempFusion Wellness to launch CBD products in Arizona retail market through key grocery channel

  • HempFusion's Stock Slightly Up On Announcing Sagely Naturals' Launch Into Top 10 US Retail Outlets

  • HempFusion subsidiary Sagely Naturals launches into Top 10 US retailer

  • HempFusion Wellness promotes Maria Leal to the post of chief financial officer

  • HempFusion Wellness closes previously announced private placement for gross proceeds of approximately US$2.94 million

  • HempFusion Wellness closes previously announced private placement for gross proceeds of approximately US$2.94 million

  • HempFusion Wellness increases its private placement to over US$2.5M due to greater investor demand

  • HempFusion Wellness reveals US$2M strategic private placement

  • HempFusion Wellness expansion plans expected to boost its FY2021 revenue to between US$12.5M and US$13.5M

  • HempFusion Wellness expansion plans expected to boost its FY2021 revenue to US$12.5M to US$13.5M